Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-1 (IL-1) family of cytokines: Role in Type 2 Diabetes
Monisha Banerjee, Madhukar Saxena
Clinica Chimica Acta (2012) Vol. 413, Iss. 15-16, pp. 1163-1170
Closed Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
John R. Petrie, Tomasz J. Guzik, Rhian M. Touyz
Canadian Journal of Cardiology (2017) Vol. 34, Iss. 5, pp. 575-584
Open Access | Times Cited: 1463
Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation
Jamaludin Mohamed, Nazratun Nafizah A. H., A. H. Zariyantey, et al.
Sultan Qaboos University medical journal (2016) Vol. 16, Iss. 2, pp. e132-141
Open Access | Times Cited: 391
Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation
Sujatha Muralidharan, Pranoti Mandrekar
Journal of Leukocyte Biology (2013) Vol. 94, Iss. 6, pp. 1167-1184
Open Access | Times Cited: 287
Frailty, Sarcopenia and Diabetes
John E. Morley, Theodore K. Malmstrom, Leocadio Rodríguez‐Mañas, et al.
Journal of the American Medical Directors Association (2014) Vol. 15, Iss. 12, pp. 853-859
Closed Access | Times Cited: 260
Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease
Nathalie Esser, Nicolas Paquot, André Scheen
Expert Opinion on Investigational Drugs (2014) Vol. 24, Iss. 3, pp. 283-307
Closed Access | Times Cited: 240
Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
Dario Siniscalco, Stephen Schultz, Anna Lisa Brigida, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 2, pp. 56-56
Open Access | Times Cited: 238
Cytokines and Abnormal Glucose and Lipid Metabolism
Jie Shi, Jian‐Gao Fan, Qing Su, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 218
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 134-157
Closed Access | Times Cited: 127
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Targeting IL-1 in depression
Michaël Maes, Cai Song, Raz Yirmiya
Expert Opinion on Therapeutic Targets (2012) Vol. 16, Iss. 11, pp. 1097-1112
Closed Access | Times Cited: 152
Diabetes and Risk of Cancer
Samy L. Habib, Maciej Rojna
ISRN Oncology (2013) Vol. 2013, pp. 1-16
Open Access | Times Cited: 122
NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Ilona M. Góra, Anna Ciechanowska, Piotr Ładyżyński
Cells (2021) Vol. 10, Iss. 2, pp. 314-314
Open Access | Times Cited: 98
Where frailty meets diabetes
Stany Perkisas, M. Vandewoude
Diabetes/Metabolism Research and Reviews (2015) Vol. 32, Iss. S1, pp. 261-267
Open Access | Times Cited: 97
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis
Emma McAlister, Melissa Kirkby, Juan Domínguez‐Robles, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113825-113825
Open Access | Times Cited: 56
Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
Jingxue Ye, Lanfang Li, Min Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis
Hend Alfadul, Shaun Sabico, Nasser M. Al‐Daghri
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
Quercetin and Kaempferol as Multi-Targeting Antidiabetic Agents against Mouse Model of Chemically Induced Type 2 Diabetes
Muhammad Ali, Mudassir Hassan, Siddique Akber Ansari, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 757-757
Open Access | Times Cited: 9
The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial
Metha Yaikwawong, Laddawan Jansarikit, Siwanon Jirawatnotai, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2441-2441
Open Access | Times Cited: 9
The association between interleukin family and diabetes mellitus and its complications: An overview of systematic reviews and meta-analyses
Zishan Jin, Qiqi Zhang, Ke Liu, et al.
Diabetes Research and Clinical Practice (2024) Vol. 210, pp. 111615-111615
Closed Access | Times Cited: 8
Association between suicidal behaviour and impaired glucose metabolism in depressive disorders
Hannu Koponen, Hannu Kautiainen, Esa Leppänen, et al.
BMC Psychiatry (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 87
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Antonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 83
Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas
Chenxi Yan, Nan Gao, Haijing Sun, et al.
American Journal Of Pathology (2016) Vol. 186, Iss. 6, pp. 1466-1480
Open Access | Times Cited: 80
Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains
Etheresia Pretorius, Martin Pagé, Lize Engelbrecht, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 71
Kolaviron, a biflavonoid complex of Garcinia kola seeds modulates apoptosis by suppressing oxidative stress and inflammation in diabetes-induced nephrotoxic rats
Omolola R. Ayepola, Marlon E. Cerf, Nicole Brooks, et al.
Phytomedicine (2014) Vol. 21, Iss. 14, pp. 1785-1793
Open Access | Times Cited: 68
Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications
Mohamed Noureldein, Sara Bitar, Natalie Youssef, et al.
Journal of Molecular Endocrinology (2019) Vol. 64, Iss. 1, pp. 29-42
Open Access | Times Cited: 68
Page 1 - Next Page

Scroll to top